Lung cancer stage 4 Doctors Abroad — Page 2

900+ lung cancer treatments performed – Saban Sec is a Clinical Oncologist with extensive expertise in lung cancer at Valued Med Hub Hospitals.

• 14 years of experience of medical oncology experience
• Member of the Turkish Medical Oncology Association
• Specialist in lung cancer and other thoracic malignancies
• Published research on prognostic factors in non-small cell lung cancer

Associate Professor Dr. Yusuf Acikgoz brings global expertise from Ohio State University to lung cancer treatment at Lokman Hekim University Ankara Hospital.

• Specializes in advanced medical oncology with a focus on lung cancer
• Involved in international phase III clinical trials like CheckMate-649 and Fortitude-101
• Certified in Good Clinical Practice and Human Subjects Protection
• Member of American Society of Clinical Oncology (ASCO) and Turkish Society of Medical Oncology

Dr. Menahem Ben-haim is a top surgeon with over 32 years of experience of experience, specializing in gastrointestinal cancers at Sourasky Medical Center (Ichilov).

• Expert in Whipple surgery for pancreatic cancer
• Specializes in liver and gastrointestinal oncology
• Performs complex interventions for advanced cancers

Dr. Elkhan Mammadov is a medical oncologist. He focuses on cancer diagnosis and treatment, including cytotoxic chemotherapy, hormone therapy, targeted therapy (smart drugs), and immunotherapy.

Education: Azerbaijan Medical University, MD (2004–2010). Istanbul University, Istanbul Faculty of Medicine, Internal Medicine training (2014–2019). Istanbul Medipol Mega University Hospital, Medical Oncology subspecialty training (2019–2022).

Experience: 5 years in Internal Medicine. 3 years in Medical Oncology.

Memberships: Turkish Society for Medical Oncology. ESMO (European Society for Medical Oncology). ASCO (American Society of Clinical Oncology).

Professor Wolfgang Köstler is an internationally recognized oncologist focused on personalized treatments, including immunotherapy and targeted therapies. He integrates these approaches with his long-time academic and research leadership.

• Over two decades of experience as a medical oncologist and internist
• Associate Professor at the Medical University of Vienna, advancing translational research
• Former Deputy Head of the Clinical Division of Oncology at the Medical University
• Expertise in biomarker development and designing new treatment strategies

Specializes in molecular diagnostics and innovative therapies for advanced lung cancer at Medical Center in Solingen.

• 14 years of experience treating oncological diseases
• Chief Physician at BKZ Solingen's cancer center
• Develops targeted therapies through molecular biology research
• Expert in immunotherapy and palliative care
• Published researcher in haemato-oncology

Over a decade of experience treating lung cancer, specializing in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Associate Professor since 2016, with extensive academic and clinical training
• Specializes in internal medicine and oncology, ensuring comprehensive care
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital

Professor Keil specializes in advanced imaging techniques for complex lung cancer cases, with leadership roles at top German radiology centers.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Trained under renowned Professor Rolf W. Günther in Aachen
• Chief Physician at Academic Hospital Solingen since 2022
• Expert in MRI, CT, and ultrasound-guided interventions

Specializes in virotherapy – a cutting-edge approach to treating lung cancer with over 49 years of experience of experience.

• Graduate of Riga Medical Institute
• Internship in Internal Medicine
• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital

Dr. Liuying directs the Oncology Ward at Jinshazhou Hospital in Guangzhou. She specializes in minimally invasive ablation for liver, lung, and colorectal cancers. Her primary focus includes hepatocellular carcinoma and melanoma liver metastasis. Dr. Liuying contributed to the national expert consensus on thermal ablation for lung tumors.

• Performs microwave, radiofrequency, and cryoablation for non-vascular tumor treatment.
• Expert in radioactive seed implantation for brachytherapy.
• Authored clinical textbooks on microwave ablation for lung and liver tumors.
• Directs oncology at a hospital holding OECI cancer institute certification.
• Committee member for the China Medical Education Association in brachytherapy.

Professor Bilir specializes in lung cancer treatment, combining clinical expertise with academic research at Sakarya University.

• Board-certified in medical oncology with over 21 years of experience of experience
• Member of ASCO and ESMO – stays updated with global oncology standards
• Completed research fellowship at Northeastern University in Boston
• Currently pursuing Ph.D. in inorganic chemistry to enhance cancer treatment approaches

Specializes in thoracic surgical oncology, including advanced lung cancer surgeries at Medical Park Göztepe Hospital Complex. Offers VATS (Video Assisted Thoracoscopic Surgery) for precise, minimally invasive procedures.

• Extensive experience in lung cancer surgery and pleural disease treatments
• Trained at University of Paris-Sud and Marie-Lannelongu Hospital, France
• Member of the European Society of Thoracic Surgeons
• Published numerous papers on thoracic surgery topics

Dr. Ozden specializes in treating advanced lung cancer at VM Medical Park Pendik Hospital, with extensive training and practice in medical oncology.

• Graduated from Istanbul University Cerrahpaşa Faculty of Medicine
• Completed medical oncology subspecialty at Kocaeli University
• Over a decade of experience in internal medicine and oncology
• Worked at Şırnak State Hospital focusing on medical oncology

Specializes in minimally invasive robotic and thoracoscopic surgeries for lung cancer – Dr. Dobritoiu uses small incisions for faster recovery at Ponderas Academic Hospital.

• Expert in robotic thoracic surgery using da Vinci Xi system
• Performs video-assisted thoracoscopic surgery (VATS), including uniportal VATS
• Skilled in complex pulmonary and mediastinal resections
• Offers minimally invasive procedures without postoperative pleural drainage

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.

Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.